Wed.Jul 10, 2024

article thumbnail

Move over, oncology: Obesity, diabetes meds will take over 2030's top drug rankings, Evaluate forecasts

Fierce Pharma

It’s well known that obesity drugs from Novo Nordisk and Eli Lilly are on a high-flying growth trajectory that doesn’t look to be letting up anytime soon. | Novo Nordisk's Ozempic is slated to take over No.1, while Merck's Keytruda falls to No.9 on Evaluate's predicted rankings of top drugs by 2030 sales.

Sales 336
article thumbnail

Why Industry Groups Are Decrying CMS’ Physician Fee Schedule Proposal

MedCity News

CMS issued its proposed rule for next year’s Medicare physician fee schedule, revealing plans to cut payment rates by 2.8%. Industry groups swiftly expressed their outrage, arguing that reimbursement rates need to keep up with the pace of inflation. The post Why Industry Groups Are Decrying CMS’ Physician Fee Schedule Proposal appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Amid GLP-1 boom, Novo Nordisk strikes up insulin partnership in Indonesia

Fierce Pharma

While much of the attention on Novo Nordisk these days revolves around the company’s wildly popular GLP-1 drugs Ozempic and Wegovy, insulin remains a critical backbone for the drugmaker. | As Novo Nordisk steadily ups its commitments in Asia, the company is teaming up with Indonesia’s state-owned pharmaceutical firm Bio Farma to bolster insulin packaging in the southeast Asian nation.

article thumbnail

Medical Device Recycling Programs Are Manufacturer Money-Grabs Disguised as Sustainability Initiatives

MedCity News

Hospitals would be much better served by focusing on reuse and reprocessing programs. So why isn’t that happening and what can be done about it? The post Medical Device Recycling Programs Are Manufacturer Money-Grabs Disguised as Sustainability Initiatives appeared first on MedCity News.

article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Indivior slashes revenue projection and headcount, drops schizophrenia med

Fierce Pharma

Indivior has slashed its projected revenue increase for 2024 from 18% to 8%, citing competitive pressure for top-selling product Sublocade.

article thumbnail

UK DRI and NHS collaborate on digitally enabled dementia care platform

PharmaTimes

Around one in five dementia hospitalisations are due to potentially preventable causes

116
116

More Trending

article thumbnail

“Robotic-based” Home Care is Actually More … Human

MedCity News

Is it possible to be pro-human and pro-tech at the same time when it comes to our healthcare? The post “Robotic-based” Home Care is Actually More … Human appeared first on MedCity News.

article thumbnail

A look at Big Pharma’s top-paid CEOs

Fierce Pharma

Pharmaceutical CEOs often earn pay packages worth tens of millions of dollars for leading the top drugmaking companies in the industry. | In this week's episode of "The Top Line," Fierce Pharma’s Eric Sagonowsky and Fraiser Kansteiner discuss Fierce’s annual special report, “Big Pharma's 10 highest-paid CEOs.

article thumbnail

After FDA delay, Arcutis gets Zoryve OK in atopic dermatitis

pharmaphorum

After short but worrying delay, Arcutis gets FDA approval for flagship drug Zoryve in atopic dermatitis, which could further unlock sales growth

FDA 116
article thumbnail

Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think

MedCity News

Unlike GLP-1 agonist drugs marketed for weight loss, new Amylyx Pharmaceuticals drug avexitide blocks its target receptor. Amylyx plans to advance this GLP-1 antagonist into Phase 3 testing for post-bariatric hypoglycemia, a rare condition in which blood sugar levels drop precipitously. The post Amylyx Aims to Help Patients With a Novel GLP-1 Drug, But Not the Way You Think appeared first on MedCity News.

Patients 114
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Flagship closes $3.6bn biotech fund, with a focus on AI

pharmaphorum

Flagship Pioneering raises $3.

110
110
article thumbnail

NICE recommends Ebglyss for atopic dermatitis patients

Pharmaceutical Technology

Almirall’s Ebglyss is predicted to hit blockbuster status in two years in the crowded atopic dermatitis market.

Patients 105
article thumbnail

The Current Landscape of Drug Shortages

Pharmaceutical Commerce

In an interview with Pharma Commerce editor Nicholas Saraceno, Peter Ax, UpScriptHealth, founder and CEO, offers his thoughts surrounding the lack of supply.

Pharma 105
article thumbnail

NICE backs monthly eczema drug from Almirall

pharmaphorum

NICE backs monthly eczema drug from Almirall Phil.

105
105
article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

The State of Patient Support Services in Today’s Landscape

Pharmaceutical Commerce

Why these programs require a hybrid approach that combines technology and human connection.

Patients 105
article thumbnail

uniQure rockets on Huntington’s gene therapy result

pharmaphorum

Shares in Dutch biotech uniQure shoot up after Huntington’s candidate AMT-130 slows disease progression by 80% two years after dosing.

105
105
article thumbnail

Pharma Pulse 7/10/24: Study Connects Multivitamin Use With Mortality Risk, Can Data and AI Deliver Whole-Person Health? & more

Pharmaceutical Commerce

The latest news for pharma industry insiders.

Pharma 101
article thumbnail

Own Your Career: Intentional Professional Development

ALULA

Earlier this year, I had the pleasure of giving an invited talk at the Organizational Behavior Management ( OBM ) Network Conference in Houston, TX. I knew it would be a great opportunity to engage with OBM professionals and researchers on a challenge that everyone shares right now: facing the inevitability of change, particularly career change.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Evotec and Pfizer announce drug discovery collaboration

Pharmaceutical Technology

Evotec and Pfizer have entered a multi-year partnership that will focus initially on early discovery research.

98
article thumbnail

Institutions to lead £1.7m-funded network to support people at risk of dementia

PharmaTimes

The neurodegenerative condition currently affects more than 944,000 people in the UK

article thumbnail

Pfizer research chief Dolsten to step down, with company at a crossroads

PharmaVoice

The company has begun searching for a successor to Dolsten, who oversaw more than 35 drug and vaccine approvals alongside notable setbacks during his time as Pfizer’s top scientist.

98
article thumbnail

Medical Sales Rep Recruitment (Part 2): How to optimize the hiring process to select top talent.

MaBiCo

Medical Sales Rep Recruitment (Part 2): How to optimize the hiring process to select top talent. In our previous article, we explored the fundamental steps necessary for implementing an effective medical representative selection process. These steps included identifying key characteristics exhibited by top-performing salespeople and using them as benchmarks for hiring.

article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

Hello Alpha, Phenomix Sciences Launch Partnership for Genetic Obesity Test

MedCity News

A new partnership will give Hello Alpha patients access to Phenomix Sciences’ genetic obesity test. The post Hello Alpha, Phenomix Sciences Launch Partnership for Genetic Obesity Test appeared first on MedCity News.

article thumbnail

‘Sleeping beauties’: Yesterday’s findings fuel today’s research breakthroughs

Clarivate

Summary: Older research often presents fresh opportunities to advance scientific and scholarly research today. Learn more about a few notable examples. Staying up to date with the newest findings in a field is critical in today’s fast-paced research environment. Researchers need to ensure that they are pursuing novel ideas and incorporating the most recent evidence in their work.

article thumbnail

Arcutis bags FDA approval for atopic dermatitis cream after delay

Pharmaceutical Technology

The FDA has approved the once-daily topical cream for mild to moderate atopic dermatitis in patients aged six and older.

FDA 59
article thumbnail

Cisplatin-Based Chemotherapy Linked to Hearing Loss in Cancer Survivors

Pharmacy Times

Extended treatment with high doses of cisplatin-based chemotherapy is associated with severe and progressive hearing loss.

52
article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

Longeveron scores RMAT designation for Alzheimer’s cell therapy

Pharmaceutical Technology

Lomecel-B is also being investigated for treating hypoplastic left heart syndrome, and ageing-related frailty, in addition to Alzheimer’s.

59
article thumbnail

Serum : Effective mode with high concentration of actives

Pharmatutor

Serum : Effective mode with high concentration of actives Pradip Mahajan Thu, 07/11/2024 - 11:47 Vinay Kumar Singh. Head-Formulation Kumar Organic Products Research Centre Pvt. Ltd., Bengaluru Email : formulation_krc@kopresearchcentre.

52
article thumbnail

IntegriChain acquires pharma advisory services company FCS

Pharmaceutical Technology

IntegriChain, a provider of data-driven commercialisation solutions for the pharma industry, has acquired Federal Compliance Solutions (FCS).

Pharma 59
article thumbnail

What Happens to Out-of-Pocket Costs When Patients with Type 2 Diabetes Reach the Medicare Age?

PharmExec

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A